The compounding pharmacy aspect is a wild card too. It's a humiliating black eye for Ellis and everyone involved. But the post race test part worked and its odd to me that no one seems to care to acknowledge that. And the OCT portion demonstrates that the industry can be out in front of potential problems. That's something viable and productive to build on going forward.
12-22-2016, 11:12 PM
Threaded Mode